A business in context

FTH research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-11 · 0001193125-26-394360 · Items 5.02

  2. 4 · Ownership change

    Report date 2026-09-11 · 0001723884-26-000005

  3. 8-K · Current report

    Report date 2026-08-04 · 0001193125-26-331563 · Items 2.02,9.01

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-331562

  5. 4 · Ownership change

    Report date 2026-07-21 · 0002111813-26-000012

  6. 4 · Ownership change

    Report date 2026-07-21 · 0002038400-26-000004

  7. 8-K · Current report

    Report date 2026-07-21 · 0001193125-26-314591 · Items 5.02

  8. 4 · Ownership change

    Report date 2026-06-29 · 0001780030-26-000006

  9. 4 · Ownership change

    Report date 2026-06-24 · 0001780030-26-000005

  10. 4 · Ownership change

    Report date 2026-06-22 · 0002111813-26-000010

  11. 4 · Ownership change

    Report date 2026-06-22 · 0001780030-26-000004

  12. 8-K · Current report

    Report date 2026-06-15 · 0001193125-26-276093 · Items 1.01,8.01,9.01

  13. 4 · Ownership change

    Report date 2026-06-12 · 0002137706-26-000003

  14. 8-K · Current report

    Report date 2026-06-10 · 0001193125-26-270330 · Items 1.02,5.02,5.03,7.01,8.01,9.01

  15. 8-K · Current report

    Report date 2026-06-10 · 0001193125-26-265879 · Items 5.02,5.03,5.07,9.01

  16. 10-K/A · Annual report

    Report date 2025-12-31 · 0001193125-26-252637

  17. 8-K · Current report

    Report date 2026-05-22 · 0001193125-26-236820 · Items 8.01

  18. 8-K · Current report

    Report date 2026-05-21 · 0001193125-26-234882 · Items 8.01,9.01

  19. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-225333

  20. 8-K · Current report

    Report date 2026-05-15 · 0001193125-26-225323 · Items 2.02,9.01

  21. DEF 14A · Proxy statement

    Report date 2026-06-10 · 0001193125-26-182143

  22. 8-K · Current report

    Report date 2026-04-10 · 0001193125-26-158951 · Items 5.02

  23. 8-K/A · Current report

    Report date 2026-02-17 · 0001193125-26-157038 · Items 9.01

  24. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-132014

  25. 8-K · Current report

    Report date 2026-03-30 · 0001193125-26-130419 · Items 2.02,9.01

  26. 8-K · Current report

    Report date 2026-02-17 · 0001193125-26-056135 · Items 1.01,2.01,3.02,5.02,5.03,7.01,9.01

  27. 8-K · Current report

    Report date 2026-02-13 · 0001193125-26-051815 · Items 5.02

  28. 8-K · Current report

    Report date 2025-12-22 · 0001193125-25-331113 · Items 5.02

  29. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-281590

  30. 8-K · Current report

    Report date 2025-11-14 · 0001193125-25-281581 · Items 2.02,9.01

  31. 8-K · Current report

    Report date 2025-10-30 · 0001193125-25-257621 · Items 7.01,9.01

  32. 8-K · Current report

    Report date 2025-10-17 · 0001193125-25-242007 · Items 7.01,9.01

  33. 8-K · Current report

    Report date 2025-08-05 · 0001193125-25-173043 · Items 2.02,9.01

  34. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-103101

  35. 8-K · Current report

    Report date 2025-07-02 · 0001193125-25-157113 · Items 3.01

  36. 8-K · Current report

    Report date 2025-06-12 · 0001193125-25-140329 · Items 5.03,9.01

  37. 8-K · Current report

    Report date 2025-05-21 · 0001193125-25-125484 · Items 5.07

  38. 8-K · Current report

    Report date 2025-05-06 · 0001193125-25-113299 · Items 2.02,9.01

  39. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-064525

  40. DEF 14A · Proxy statement

    Report date 2025-05-21 · 0000950170-25-053033

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 6 transaction rows6PSale: 0 transaction rows0SGrant / award: 3 transaction rows3AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

9 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-11
2026-09-15
Vousden Karen HA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
25000.00.0
2026-07-21
2026-07-23
Parikh Anand KiranA · Grant / award
Acquired
Performance-Based Stock Option (right to buy)
Derivative security
398018.00.0
2026-07-21
2026-07-23
Craver JosiahA · Grant / award
Acquired
Performance-Based Stock Option (right to buy)
Derivative security
30824.00.0
2026-07-01
2026-07-01
STEPHENSON BRIAN CP · Purchase
Acquired
Common Stock600.024.22
2026-07-01
2026-07-01
STEPHENSON BRIAN CP · Purchase
Acquired
Common Stock4400.023.4
2026-06-30
2026-07-01
STEPHENSON BRIAN CP · Purchase
Acquired
Common Stock1638.023.88
2026-06-30
2026-07-01
STEPHENSON BRIAN CP · Purchase
Acquired
Common Stock1910.022.95
2026-06-30
2026-07-01
STEPHENSON BRIAN CP · Purchase
Acquired
Common Stock4255.024.98
2026-06-29
2026-07-01
STEPHENSON BRIAN CP · Purchase
Acquired
Common Stock831.023.34

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001829802Faeth Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names
  • Sensei Biotherapeutics, Inc. · former SEC name · 2020-11-12 to 2026-06-16

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗